Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-25-014237
Filing Date
2025-09-19
Accepted
2025-09-19 16:05:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5355
  Complete submission text file 0001493152-25-014237.txt   7022
Mailing Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124
Business Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124 8012789769
Co-Diagnostics, Inc. (Subject) CIK: 0001692415 (see all company filings)

EIN.: 462609396 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90782 | Film No.: 251326842
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address SPERLRING 2 PFAFFENHOFEN 2M 85276
Business Address SPERLRING 2 PFAFFENHOFEN 2M 85276 498441 78644 14
Orca Capital AG (Filed by) CIK: 0002052389 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SCHEDULE 13G/A